These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Behaviour after transplantation of brain cells into monkey models of Parkinson's disease]. Liu ZG; Chen S; Yu H Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):683-6. PubMed ID: 9772539 [TBL] [Abstract][Full Text] [Related]
3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
4. Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans. Kopin IJ; Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Oldfield EH Adv Neurol; 1993; 60():707-14. PubMed ID: 8420215 [No Abstract] [Full Text] [Related]
5. Brain grafts and Parkinson's disease. Freed WJ; Poltorak M; Takashima H; LaMarca ME; Ginns EI J Cell Biochem; 1991 Mar; 45(3):261-7. PubMed ID: 2066376 [TBL] [Abstract][Full Text] [Related]
6. The MPTP model of Parkinson's disease. Smeyne RJ; Jackson-Lewis V Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530 [TBL] [Abstract][Full Text] [Related]
7. [Aging and Parkinson's disease]. Tohgi H; Abe T; Takahashi S No To Shinkei; 1991 Aug; 43(8):713-9. PubMed ID: 1931254 [No Abstract] [Full Text] [Related]
13. Pathogenesis and animal studies of Parkinson's disease. Oertel WH; Kupsch A Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901 [TBL] [Abstract][Full Text] [Related]
14. Functional effects of transplanted human fetal ventral mesencephalic brain tissue from spontaneous abortions into a rodent model of Parkinson's disease. Kondoh T; Blount JP; Conrad JA; Pundt LL; Low WC Transplant Proc; 1994 Dec; 26(6):3335. PubMed ID: 7998161 [No Abstract] [Full Text] [Related]
15. Fetal-tissue transplants in Parkinson's disease. Fahn S N Engl J Med; 1992 Nov; 327(22):1589-90. PubMed ID: 1435887 [No Abstract] [Full Text] [Related]
16. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease. Haque NS; Hlavin ML; Fawcett J; Dunnett SB Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406 [No Abstract] [Full Text] [Related]
17. Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism. Widner H; Tetrud J; Rehncrona S; Snow BJ; Brundin P; Björklund A; Lindvall O; Langston JW Adv Neurol; 1993; 60():729-33. PubMed ID: 8420218 [No Abstract] [Full Text] [Related]
18. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Taylor JR; Elsworth JD; Roth RH; Sladek JR; Collier TJ; Redmond DE Exp Brain Res; 1991; 85(2):335-48. PubMed ID: 1893983 [TBL] [Abstract][Full Text] [Related]
19. Transplantation of fetal mesencephalic tissue in Parkinson's disease. Freed CR; Breeze RE; Schneck SA N Engl J Med; 1995 Sep; 333(11):730-1. PubMed ID: 7637761 [No Abstract] [Full Text] [Related]